The QT Interval in Patients With the Turner Syndrome

•Patients with Turner syndrome have a longer corrected QT interval compared with matched controls.•Patients with Turner syndrome are commonly prescribed QTc prolonging medications.•Patients with Turner syndrome are not at greater risk for ventricular arrhythmias. Patients with the Turner syndrome (T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2021-02, Vol.140, p.118-121
Hauptverfasser: Harrahill, Noah J., Yetman, Anji T., Danford, David A., Starr, Lois J., Sanmann, Jennifer N., Robinson, Jeffrey A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Patients with Turner syndrome have a longer corrected QT interval compared with matched controls.•Patients with Turner syndrome are commonly prescribed QTc prolonging medications.•Patients with Turner syndrome are not at greater risk for ventricular arrhythmias. Patients with the Turner syndrome (TS) often have longer QT intervals compared with age-matched peers although the significance of this remains unknown. We sought to determine the degree, frequency and impact of QTc prolongation in patients with TS. A chart review of all patients with an electrocardiogram (ECG) and genetically proven TS was performed. Medications at the time of the ECG were reviewed and QTc calculated. Medications were classified according to QTc risk using www.crediblemeds.com. ECG parameters were compared with an age, gender, and cardiac lesion-matched control group. Over the 10-year period of review, 112 TS patients with a mean age of 34 ± 25 years underwent 226 ECGs. At least 1 QTc prolonging medication was prescribed in 81 (74%) patients. Longer QTc interval correlated with absence of y chromosomal material (p = 0.01), older age (p
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2020.09.061